SCHEMBL135145

SCHEMBL135145

CN(C)c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.57
CYP3A4 P08684 3/20 0.57
ALDH1A1 P00352 9/20 0.52
TSHR P16473 4/20 0.52
HSD17B10 Q99714 2/20 0.52
ALOX15 P16050 2/20 0.52
MAPK1 P28482 4/20 0.50
ESR1 P03372 2/20 0.50
ESR2 Q92731 2/20 0.50
RELA Q04206 1/20 0.50
RAB9A P51151 3/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
HPGD P15428 2/20 0.47
NPC1 O15118 2/20 0.47
GFER P55789 1/20 0.44
KDM4E B2RXH2 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
GLA P06280 1/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9838144 1.00 TDP1 (0.57) TDP1CYP3A4ALDH1A1TSHRHSD17B10
SCHEMBL16965834 0.98 TDP1 (0.55) TDP1CYP3A4ALDH1A1TSHRHSD17B10
SCHEMBL31325538 0.98 TDP1 (0.55) TDP1CYP3A4ALDH1A1TSHRHSD17B10
Hydrochloric Acid SCHEMBL9007656 0.98 TDP1 (0.55) TDP1CYP3A4ALDH1A1TSHRHSD17B10
SCHEMBL16965836 0.98 TDP1 (0.55) TDP1CYP3A4ALDH1A1TSHRHSD17B10
Iodide SCHEMBL29884191 0.98 TDP1 (0.55) TDP1CYP3A4ALDH1A1TSHRHSD17B10
Formaldehyde SCHEMBL16965491 0.92 TDP1 (0.48) TDP1CYP3A4ALDH1A1TSHRHSD17B10
Formaldehyde SCHEMBL16965832 0.92 TDP1 (0.48) TDP1CYP3A4ALDH1A1TSHRHSD17B10
SCHEMBL735682 0.90 ALDH1A1 (0.65) TDP1CYP3A4ALDH1A1TSHRHSD17B10
SCHEMBL15657282 0.90 ALDH1A1 (0.65) TDP1CYP3A4ALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 822 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026103385-A1 INTEGRATED PREPARATION METHOD FOR IRON-BASED PHOSPHATE MATERIAL FOR POSITIVE ELECTRODE OF SECONDARY BATTERY 深圳珈钠能源科技有限公司 2026-05-21 WO claimed
US-20250361258-A1 PROCESSES FOR MAKING PRMT5 INHIBITORS PRELUDE THERAPEUTICS INC (US) 2025-11-27 US claimed
EP-4321501-B1 METHOD FOR SYNTHESIZING DIMETHYL 3-(3-OXO-2-PENTYL)CYCLOPENTYLMALONATE AND CATALYST ZHEJIANG XINHUA CHEMICAL CO LTD (CN) 2025-10-01 EP claimed
CN-120035598-A Method for preparing PRMT5 inhibitor 普莱鲁德疗法股份有限公司 2025-05-23 CN claimed
WO-2025106936-A1 POLY(METH)ACRYLIMIDE MATERIALS WITH ENHANCED THERMOMECHANICAL PROPERTIES GENCORES, INC. (US) 2025-05-22 WO claimed
EP-4540261-A1 PROCESSES FOR MAKING PRMT5 INHIBITORS Prelude Therapeutics Incorporated (US) 2025-04-23 EP claimed
WO-2025068962-A1 CATALYST COMPOSITION FOR OLIGOMERIZATION AND A PROCESS FOR ITS PREPARATION RELIANCE INDUSTRIES LIMITED (IN) 2025-04-03 WO claimed
CN-119503752-A Integrated preparation method of secondary battery anode iron-based phosphate material 深圳珈钠能源科技有限公司 2025-02-25 CN claimed
US-12209107-B2 Process for preparing high puritiy allopregnanolone and intermediates thereof CRYSTAL PHARMA, S.A.U. (ES) 2025-01-28 US claimed
US-20240409490-A1 SYNTHETIC METHOD AND CATALYST OF 3-(3-OXO-2-PENTYL)CYCLOPENTYL DIMETHYL MALONATE Ningxia Xinhua Chemical Co., Ltd. (CN) 2024-12-12 US claimed
WO-2007137260-A2 PREPARATION OF POLYMER CONJUGATES OF VLA-4 ANTAGONISTS VIA A MITSUNOBU' S REACTION ELAN PHARMACEUTICALS, INC. (US) 2007-11-29 WO claimed
EP-1598053-B1 Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres OREAL (FR) 2006-12-20 EP claimed
EP-1021709-A4 ELECTROPHORESIS SEPARATION METHODS MACQUARIE RES LTD (AU) 2006-01-25 EP claimed
EP-1598053-A1 Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres L'OREAL (FR) 2005-11-23 EP claimed
US-20050251928-A1 Method for stripping artificial color from keratin fibers L'OREAL (FR) 2005-11-17 US claimed
US-20040108209-A1 Electrophoresis separation methods MACQUARIE RESEARCH LTD. 2004-06-10 US claimed
EP-1021709-A1 ELECTROPHORESIS SEPARATION METHODS Macquarie Research Ltd. (AU) 2000-07-26 EP claimed
WO-1998025135-A1 ELECTROPHORESIS SEPARATION METHODS MACQUARIE RESEARCH LTD. (AU) 1998-06-11 WO claimed
EP-0496393-B1 Alkylation of azaglycine derivatives HOECHST AG (DE) 1995-01-25 EP claimed
US-5326875-A Alkylation of azaglycine derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1994-07-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240409490-A1 SYNTHETIC METHOD AND CATALYST OF 3-(3-OXO-2-PENTYL)CYCLOPENTYL DIMETHYL MALONATE MVD, FDPS, PPIP5K2 TDP1 4587/4885CYP3A4 639/4885ALDH1A1 3188/4885
US-20250361258-A1 PROCESSES FOR MAKING PRMT5 INHIBITORS PRMT1, PRMT5, PRMT6 TDP1 498/4885CYP3A4 455/4885ALDH1A1 1309/4885
US-20050251928-A1 Method for stripping artificial color from keratin fibers KRT18, DSG1, JUP TDP1 3996/4885CYP3A4 4442/4885ALDH1A1 4512/4885
US-12209107-B2 Process for preparing high puritiy allopregnanolone and intermediates thereof CYP21A2, CYP17A1, CYP11B1 TDP1 4026/4885CYP3A4 62/4885ALDH1A1 561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.